Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Apoa1 | |
NM_009692 |
apolipoprotein A-I (Apoa1), mRNA [NM_009692] |
KLA | .99 |
1.00 |
1.00 |
1.02 |
1.01 |
1.02 |
.98 |
| ATP | 1.00 |
1.00 |
1.02 |
1.16 |
1.03 |
1.04 |
1.01 |
| KLA/ATP | 1.00 |
1.03 |
1.07 |
1.23 |
1.10 |
1.05 |
.98 |
|
EG629860
| |
M17953 |
gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] |
KLA | .96 |
1.05 |
1.03 |
1.08 |
1.08 |
1.02 |
.98 |
| ATP | .97 |
.99 |
1.05 |
1.10 |
.95 |
.94 |
.91 |
| KLA/ATP | .96 |
.94 |
.97 |
1.04 |
.97 |
1.01 |
.89 |
|
F2rl1 | |
NM_007974 |
coagulation factor II (thrombin) receptor-like 1 (F2rl1), mRNA [NM_007974] |
KLA | 1.03 |
1.05 |
1.00 |
.98 |
1.01 |
1.03 |
1.04 |
| ATP | 1.00 |
.99 |
1.03 |
1.09 |
1.03 |
1.04 |
1.09 |
| KLA/ATP | 1.07 |
1.02 |
.95 |
1.10 |
1.02 |
1.02 |
1.02 |
|
Fas | |
AK086933 |
0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030012O08 product:tumor necrosis factor receptor superfamily, member 6, full insert sequence. [AK086933] |
KLA | 6.31 |
6.56 |
6.33 |
6.70 |
4.93 |
3.74 |
2.48 |
| ATP | .95 |
1.04 |
1.33 |
1.55 |
1.85 |
6.00 |
2.77 |
| KLA/ATP | 5.67 |
7.16 |
7.71 |
7.73 |
6.02 |
5.79 |
7.85 |
|
Fas | |
NM_007987 |
Fas (TNF receptor superfamily member 6) (Fas), mRNA [NM_007987] |
KLA | 17.08 |
17.45 |
19.08 |
17.38 |
13.33 |
6.78 |
4.46 |
| ATP | .98 |
.96 |
1.64 |
3.05 |
5.58 |
12.91 |
1.89 |
| KLA/ATP | 16.57 |
17.25 |
26.06 |
23.57 |
22.03 |
16.74 |
13.29 |
|
Fasl | |
NM_010177 |
Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] |
KLA | 1.03 |
1.01 |
1.03 |
1.02 |
1.01 |
1.01 |
1.00 |
| ATP | 1.00 |
.99 |
1.04 |
1.21 |
1.18 |
1.20 |
1.01 |
| KLA/ATP | 1.00 |
1.02 |
1.07 |
1.16 |
1.18 |
1.23 |
1.00 |
|
Gnaq | |
NM_008139 |
guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] |
KLA | .82 |
.82 |
.69 |
.64 |
.60 |
.55 |
.55 |
| ATP | 1.06 |
1.02 |
.87 |
.67 |
.50 |
.66 |
.57 |
| KLA/ATP | .82 |
.79 |
.66 |
.55 |
.41 |
.33 |
.48 |
|
Hba-a1 | |
NM_008218 |
hemoglobin alpha, adult chain 1 (Hba-a1), mRNA [NM_008218] |
KLA | 1.02 |
1.05 |
1.06 |
1.01 |
1.04 |
1.02 |
1.01 |
| ATP | 1.00 |
1.04 |
1.10 |
1.05 |
.98 |
.99 |
1.06 |
| KLA/ATP | 1.02 |
.99 |
1.10 |
.98 |
.95 |
1.00 |
1.02 |
|
Hba-a2 | |
M10466 |
gb|Mouse alpha-globin mRNA. [M10466] |
KLA | 1.16 |
1.09 |
1.19 |
1.12 |
1.19 |
1.24 |
1.21 |
| ATP | .96 |
1.00 |
1.07 |
1.05 |
.97 |
1.07 |
1.18 |
| KLA/ATP | 1.09 |
1.08 |
1.16 |
1.14 |
1.14 |
1.09 |
1.27 |
|
Hbb-b1 | |
NM_008220 |
hemoglobin, beta adult major chain (Hbb-b1), mRNA [NM_008220] |
KLA | 1.11 |
1.11 |
1.10 |
1.11 |
1.07 |
1.09 |
.99 |
| ATP | 1.01 |
1.01 |
1.01 |
1.04 |
1.03 |
1.07 |
1.02 |
| KLA/ATP | 1.06 |
1.12 |
1.15 |
1.09 |
1.09 |
1.45 |
1.45 |
|
Icam1 | |
BC008626 |
intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] |
KLA | 36.67 |
32.93 |
28.63 |
27.91 |
14.65 |
8.16 |
4.15 |
| ATP | .96 |
.88 |
1.50 |
3.88 |
4.98 |
3.90 |
1.01 |
| KLA/ATP | 32.58 |
31.60 |
42.74 |
32.60 |
26.00 |
13.02 |
6.01 |
|
Icam1 | |
NM_010493 |
intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] |
KLA | 15.66 |
15.20 |
12.96 |
12.31 |
9.39 |
6.17 |
3.81 |
| ATP | .96 |
1.06 |
1.21 |
4.19 |
4.33 |
3.16 |
1.06 |
| KLA/ATP | 14.31 |
15.46 |
17.84 |
17.60 |
13.77 |
8.36 |
5.42 |
|
Ifng | |
NM_008337 |
interferon gamma (Ifng), mRNA [NM_008337] |
KLA | 1.05 |
1.02 |
1.01 |
1.01 |
1.01 |
1.04 |
1.00 |
| ATP | 1.00 |
1.01 |
1.01 |
.98 |
.97 |
1.04 |
1.03 |
| KLA/ATP | 1.01 |
1.01 |
1.06 |
1.10 |
1.24 |
1.10 |
1.04 |
|
Igh-VJ55 8 | |
AY547436 |
immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] |
KLA | 1.06 |
1.05 |
1.01 |
.93 |
1.03 |
.96 |
.93 |
| ATP | .99 |
1.00 |
1.06 |
.95 |
.96 |
1.06 |
1.05 |
| KLA/ATP | .98 |
.94 |
1.07 |
.95 |
.97 |
.99 |
1.02 |
|
Igh-VJ55 8 | |
CA578712 |
gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] |
KLA | .99 |
.94 |
1.01 |
1.10 |
.93 |
.97 |
.92 |
| ATP | .93 |
1.04 |
1.01 |
.98 |
1.05 |
.96 |
.95 |
| KLA/ATP | .99 |
.95 |
.95 |
.98 |
1.02 |
.98 |
.95 |
|
Igh-VJ55 8 | |
ENSMUST00000103412 |
ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] |
KLA | 1.01 |
.97 |
1.20 |
1.01 |
.98 |
1.44 |
1.24 |
| ATP | .99 |
.98 |
1.07 |
1.03 |
1.00 |
1.01 |
1.21 |
| KLA/ATP | .99 |
1.02 |
.96 |
1.03 |
.97 |
1.13 |
1.30 |
|
Igh-VJ55 8 | |
ENSMUST00000103413 |
ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] |
KLA | 1.00 |
.99 |
1.06 |
1.06 |
.99 |
1.03 |
1.02 |
| ATP | 1.08 |
1.06 |
1.06 |
1.06 |
1.02 |
1.06 |
.95 |
| KLA/ATP | 1.00 |
1.04 |
1.09 |
1.02 |
1.06 |
1.02 |
.95 |
|
Igh-VJ55 8 | |
U39781 |
J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] |
KLA | .93 |
.89 |
.98 |
.97 |
1.03 |
1.00 |
.94 |
| ATP | 1.04 |
1.02 |
1.08 |
.94 |
.93 |
.90 |
.79 |
| KLA/ATP | .88 |
.89 |
.97 |
.93 |
.88 |
.92 |
.82 |
|
Il10 | |
NM_010548 |
interleukin 10 (Il10), mRNA [NM_010548] |
KLA | 17.59 |
18.64 |
22.22 |
23.06 |
11.83 |
8.27 |
2.07 |
| ATP | 1.86 |
3.22 |
7.72 |
20.51 |
25.86 |
8.38 |
1.01 |
| KLA/ATP | 17.91 |
23.49 |
34.53 |
34.48 |
20.98 |
12.03 |
8.17 |
|
Il12a | |
NM_008351 |
interleukin 12a (Il12a), mRNA [NM_008351] |
KLA | 2.37 |
2.47 |
2.17 |
1.49 |
1.46 |
1.12 |
1.20 |
| ATP | 1.01 |
.97 |
1.12 |
1.07 |
1.02 |
1.07 |
1.06 |
| KLA/ATP | 2.01 |
2.76 |
2.54 |
1.70 |
1.08 |
1.10 |
1.27 |
|
Il12b | |
NM_008352 |
interleukin 12b (Il12b), mRNA [NM_008352] |
KLA | 194.79 |
211.32 |
198.97 |
173.01 |
142.24 |
40.28 |
3.10 |
| ATP | 1.05 |
1.10 |
1.59 |
1.99 |
2.71 |
2.72 |
1.52 |
| KLA/ATP | 191.27 |
223.23 |
280.10 |
224.29 |
183.03 |
68.43 |
10.69 |
|
Il18 | |
NM_008360 |
interleukin 18 (Il18), mRNA [NM_008360] |
KLA | 12.14 |
11.96 |
12.28 |
12.96 |
12.23 |
7.84 |
2.40 |
| ATP | 1.06 |
.96 |
1.13 |
1.04 |
.92 |
1.67 |
2.29 |
| KLA/ATP | 11.55 |
11.63 |
13.03 |
9.98 |
9.08 |
6.50 |
6.72 |
|
Il1b | |
NM_008361 |
interleukin 1 beta (Il1b), mRNA [NM_008361] |
KLA | 149.78 |
133.59 |
100.91 |
116.58 |
86.48 |
89.37 |
64.72 |
| ATP | 3.49 |
13.96 |
61.44 |
70.91 |
82.12 |
162.79 |
28.18 |
| KLA/ATP | 130.32 |
139.00 |
219.12 |
148.17 |
165.44 |
172.57 |
146.98 |
|
Il6 | |
NM_031168 |
interleukin 6 (Il6), mRNA [NM_031168] |
KLA | 352.99 |
378.70 |
276.81 |
168.47 |
59.99 |
18.66 |
8.27 |
| ATP | 1.04 |
1.08 |
2.28 |
3.69 |
30.40 |
161.93 |
2.11 |
| KLA/ATP | 334.28 |
528.66 |
###.## |
935.86 |
302.45 |
355.36 |
99.65 |
|
Indo | |
NM_008324 |
indoleamine-pyrrole 2,3 dioxygenase (Indo), mRNA [NM_008324] |
KLA | 1.56 |
1.62 |
1.87 |
1.73 |
1.52 |
1.38 |
1.28 |
| ATP | 1.09 |
1.01 |
1.08 |
1.02 |
1.00 |
1.06 |
1.07 |
| KLA/ATP | 1.53 |
1.60 |
1.78 |
1.50 |
1.49 |
1.40 |
3.38 |
|
Indol1 | |
NM_145949 |
indoleamine-pyrrole 2,3 dioxygenase-like 1 (Indol1), mRNA [NM_145949] |
KLA | 2.01 |
2.13 |
2.31 |
2.13 |
2.14 |
2.14 |
2.52 |
| ATP | .96 |
.98 |
1.06 |
1.12 |
.99 |
1.18 |
1.25 |
| KLA/ATP | 2.03 |
2.15 |
1.83 |
1.54 |
1.38 |
1.32 |
2.07 |
|
Lama4 | |
NM_010681 |
laminin, alpha 4 (Lama4), mRNA [NM_010681] |
KLA | .99 |
.99 |
1.01 |
1.02 |
.98 |
.97 |
.96 |
| ATP | 1.00 |
1.08 |
1.05 |
1.05 |
1.03 |
1.04 |
.96 |
| KLA/ATP | 1.00 |
1.03 |
.93 |
1.00 |
.94 |
.90 |
.95 |
|
Mm.19611 0 | |
145301548 |
Unknown |
KLA | 1.11 |
1.20 |
1.32 |
1.25 |
1.20 |
1.28 |
1.23 |
| ATP | 1.08 |
1.11 |
1.22 |
1.29 |
1.08 |
1.13 |
1.01 |
| KLA/ATP | 1.20 |
1.19 |
1.40 |
1.17 |
1.24 |
1.18 |
1.11 |
|
Mm.25806 5 | |
148747407 |
Unknown |
KLA | 1.05 |
1.02 |
1.03 |
1.00 |
.99 |
1.05 |
.94 |
| ATP | .98 |
.98 |
1.03 |
1.02 |
.99 |
1.06 |
1.03 |
| KLA/ATP | 1.01 |
1.02 |
1.03 |
1.01 |
.96 |
.98 |
1.01 |
|
Mm.26995
| |
141801686 |
Unknown |
KLA | .97 |
.97 |
.91 |
.96 |
.93 |
.86 |
1.03 |
| ATP | 1.09 |
.99 |
.94 |
.98 |
.96 |
.82 |
.96 |
| KLA/ATP | .97 |
1.01 |
1.01 |
.92 |
.87 |
.84 |
.87 |
|
Mm.44160 1 | |
145966786 |
Unknown |
KLA | 1.08 |
.94 |
1.01 |
.97 |
.79 |
.78 |
.71 |
| ATP | 1.09 |
.92 |
1.10 |
.75 |
.65 |
.92 |
.69 |
| KLA/ATP | 1.01 |
.92 |
1.16 |
.81 |
.69 |
.56 |
.63 |
|
Mm.44889
| |
157057165 |
Unknown |
KLA | 1.20 |
1.25 |
1.45 |
1.49 |
1.63 |
1.70 |
1.66 |
| ATP | 1.00 |
1.03 |
1.03 |
1.00 |
1.12 |
1.06 |
1.23 |
| KLA/ATP | 1.25 |
1.15 |
1.16 |
1.16 |
1.15 |
1.41 |
1.71 |
|
Mm.5245 | |
118130193 |
Unknown |
KLA | 1.62 |
1.58 |
1.58 |
1.32 |
1.15 |
1.18 |
1.17 |
| ATP | .95 |
.99 |
1.18 |
1.78 |
1.34 |
1.15 |
1.03 |
| KLA/ATP | 1.66 |
1.70 |
1.66 |
1.59 |
1.28 |
1.23 |
1.01 |
|
Mm.874 | |
6754317 |
Unknown |
KLA | 24.98 |
24.87 |
26.43 |
39.61 |
12.88 |
8.64 |
1.63 |
| ATP | 1.97 |
3.50 |
11.05 |
28.47 |
38.30 |
10.44 |
.65 |
| KLA/ATP | 23.45 |
29.37 |
58.52 |
51.77 |
30.64 |
14.61 |
8.63 |
|
Myd88 | |
NM_010851 |
myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] |
KLA | 3.35 |
3.51 |
3.91 |
4.13 |
4.13 |
3.62 |
2.53 |
| ATP | .99 |
.96 |
.79 |
.75 |
.93 |
2.15 |
1.60 |
| KLA/ATP | 3.37 |
3.52 |
3.52 |
3.48 |
2.81 |
3.03 |
3.33 |
|
Plcb1 | |
AK129166 |
mRNA for mKIAA0581 protein [AK129166] |
KLA | 1.02 |
.98 |
.91 |
.91 |
.92 |
.95 |
.89 |
| ATP | 1.03 |
1.02 |
1.02 |
1.01 |
.90 |
1.02 |
1.04 |
| KLA/ATP | .98 |
.97 |
.91 |
.93 |
.92 |
1.01 |
1.16 |
|
Plcb1 | |
NM_019677 |
phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] |
KLA | .99 |
.94 |
.95 |
.97 |
.93 |
.92 |
.91 |
| ATP | 1.00 |
.96 |
.99 |
.95 |
.99 |
1.03 |
.98 |
| KLA/ATP | .93 |
.96 |
.94 |
.93 |
.87 |
1.00 |
1.06 |
|
Plcb2 | |
NM_177568 |
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] |
KLA | .70 |
.68 |
.64 |
.67 |
.65 |
.76 |
.88 |
| ATP | .95 |
.94 |
1.04 |
.94 |
.72 |
.57 |
1.19 |
| KLA/ATP | .69 |
.68 |
.72 |
.63 |
.65 |
.55 |
.70 |
|
Plcb3 | |
NM_008874 |
phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] |
KLA | 1.72 |
1.78 |
1.82 |
1.65 |
1.67 |
1.44 |
1.21 |
| ATP | .97 |
1.04 |
.81 |
.87 |
.78 |
.88 |
.94 |
| KLA/ATP | 1.69 |
1.89 |
1.44 |
1.66 |
1.12 |
.73 |
.93 |
|
Plcb4 | |
AK082509 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] |
KLA | 1.06 |
1.03 |
.97 |
.98 |
1.02 |
1.01 |
.99 |
| ATP | .99 |
1.07 |
1.09 |
.95 |
.97 |
.97 |
1.02 |
| KLA/ATP | .98 |
1.00 |
1.03 |
.96 |
1.02 |
.91 |
.98 |
|
Plcb4 | |
NM_013829 |
phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] |
KLA | .88 |
.94 |
.81 |
.82 |
.81 |
.86 |
1.01 |
| ATP | 1.00 |
1.01 |
.92 |
.93 |
.88 |
.85 |
.89 |
| KLA/ATP | .97 |
.94 |
.78 |
.80 |
.78 |
.86 |
.97 |
|
Prkca | |
NM_011101 |
protein kinase C, alpha (Prkca), mRNA [NM_011101] |
KLA | 1.00 |
.96 |
.94 |
.95 |
.95 |
.89 |
.96 |
| ATP | 1.00 |
1.03 |
.91 |
.94 |
.82 |
.87 |
1.13 |
| KLA/ATP | 1.02 |
.95 |
.91 |
.86 |
.78 |
.84 |
.94 |
|
Prkcb1 | |
NM_008855 |
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] |
KLA | .92 |
.95 |
.93 |
.78 |
.77 |
1.08 |
1.83 |
| ATP | 1.03 |
1.12 |
1.09 |
1.23 |
.90 |
2.08 |
.96 |
| KLA/ATP | .98 |
.99 |
.82 |
.89 |
.62 |
1.01 |
1.08 |
|
Prkcc | |
NM_011102 |
protein kinase C, gamma (Prkcc), mRNA [NM_011102] |
KLA | 1.02 |
1.04 |
1.11 |
1.04 |
.96 |
1.02 |
1.05 |
| ATP | .98 |
.98 |
1.05 |
1.03 |
1.08 |
.96 |
.95 |
| KLA/ATP | 1.21 |
1.16 |
1.09 |
1.07 |
1.04 |
.98 |
.93 |
|
Sele | |
NM_011345 |
selectin, endothelial cell (Sele), mRNA [NM_011345] |
KLA | 2.65 |
3.18 |
3.14 |
1.92 |
1.46 |
1.23 |
1.14 |
| ATP | .97 |
1.01 |
1.35 |
3.40 |
2.14 |
1.33 |
1.11 |
| KLA/ATP | 3.13 |
3.40 |
2.71 |
2.69 |
1.69 |
1.51 |
1.18 |
|
Thop1 | |
NM_022653 |
thimet oligopeptidase 1 (Thop1), mRNA [NM_022653] |
KLA | .91 |
.95 |
.89 |
.76 |
.69 |
.59 |
.80 |
| ATP | 1.03 |
1.17 |
.91 |
1.22 |
.83 |
.65 |
.93 |
| KLA/ATP | .98 |
1.01 |
.70 |
.91 |
.59 |
.57 |
.48 |
|
Tlr9 | |
NM_031178 |
toll-like receptor 9 (Tlr9), mRNA [NM_031178] |
KLA | 1.08 |
1.09 |
1.18 |
1.15 |
1.34 |
1.25 |
1.16 |
| ATP | 1.04 |
1.05 |
1.23 |
1.85 |
1.41 |
1.06 |
1.21 |
| KLA/ATP | 1.16 |
1.17 |
1.45 |
1.88 |
1.67 |
1.32 |
1.46 |
|
Tnf | |
NM_013693 |
tumor necrosis factor (Tnf), mRNA [NM_013693] |
KLA | 13.35 |
12.76 |
10.71 |
9.03 |
10.64 |
7.39 |
8.32 |
| ATP | 2.01 |
2.48 |
8.27 |
19.20 |
9.72 |
4.09 |
1.49 |
| KLA/ATP | 12.72 |
15.76 |
12.73 |
17.34 |
5.10 |
3.61 |
6.07 |
|
Vcam1 | |
NM_011693 |
vascular cell adhesion molecule 1 (Vcam1), mRNA [NM_011693] |
KLA | 18.71 |
22.30 |
20.87 |
18.09 |
13.61 |
6.09 |
2.09 |
| ATP | 1.08 |
1.00 |
1.56 |
4.23 |
5.09 |
5.04 |
1.50 |
| KLA/ATP | 19.09 |
25.02 |
26.43 |
25.42 |
20.08 |
11.45 |
6.67 |
|